Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.

NCT05123755 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Distress Syndrome
Viral or Bacterial Infections
Pneumonia
Pneumonia, Viral
Respiratory Infection
COVID-19 Acute Respiratory Distress Syndrome

Interventions

DRUG: AV-001 Injection
DRUG: AV-001 Placebo Injection

Sponsor

Vasomune Therapeutics, Inc.